#Biotech #Bourse SEC Suspects Insider Trading in Onyx Shares - WSJ http://t.co/R5Fp7MVjHD
July 04, 2013
Publicité
/http%3A%2F%2Fs2.wsj.net%2Fimg%2Fwsj_select_p_377x107.gif)
SEC Suspects Insider Trading in Onyx Shares
The SEC has frozen the assets of a group of unnamed traders who earned $4.6 million in potentially illegal profits by trading Onyx Pharmaceuticals before the cancer drug-maker rejected an unsolicited acquisition offer from rival Amgen.